5,6,7,8-tetrahydronaphthalen-2-yl-7-fluoroalkyl-heptatrienoic acid derivatives having serum glucose reducing activity
Compounds of the formula
##STR1##
where the variables have the meaning defined in the specification are capable
of reducing serum glucose levels in diabetic mammals without the undesirable side
effect of reducing serum thyroxine levels.